Asieris licenses CEVIRA to Theramex for Europe and other markets

Asieris Pharmaceuticals said it reached an exclusive licensing agreement with Theramex for CEVIRA in Europe, Australia, New Zealand and Turkey. The agreement is subject to conditions and covers commercialization rights outside Asieris' remaining territories.